Tailored Touchscreen Colorectal Cancer Prevention in American Indian Communities

美国印第安社区的定制触摸屏结直肠癌预防

基本信息

批准号：
8505415
负责人：
K ALLEN GREINER
金额：
$ 51.37万
依托单位：
UNIVERSITY OF KANSAS MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2011
资助国家：
美国
起止时间：
2011-09-15 至 2015-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8505415
关键词：
Address Adherence Adoption Affect American Indians Awareness Behavior Behavior Therapy Behavioral Belief Cancer Etiology Caring Cessation of life Clinic Colonoscopy Colorectal Colorectal Cancer Communication Communities Computers Data Death Rate Decision Making Effectiveness Endoscopy Face Fecal occult blood Focus Groups Generic Drugs Health Health Services Accessibility Healthcare Systems Incidence Individual Institution Intention Intervention Link Mediating Mediation Medical Methodology Methods Minority Modality Modeling Multimedia Native Americans Participant Patient Self-Report Patients Planning Theory Population Population Group Prevention Primary Health Care Process Provider Randomized Recruitment Activity Reporting Rural Site Specific qualifier value Staging Surveys Testing To specify Underserved Population Work base cancer health disparity colorectal cancer prevention colorectal cancer screening comparison group computerized cost cultural values design follow-up improved innovation mortality novel preference primary care setting programs reservation-based safety net satisfaction screening tailored messaging theories touchscreen

项目摘要

DESCRIPTION (provided by applicant): Colorectal cancer (CRC) mortality disproportionately impacts minorities. Few studies have addressed screening among specific minority populations such as American Indians (AI). This study will assess the efficacy of a novel tailored touch screen computer intervention based on an innovative integration of the Precaution Adoption Process Model (PAPM) and the concept of "implementation intentions," a recent elaboration of the Theory of Planned Behavior. The majority of the intervention will be delivered in tribal clinics and primary care settings on low-cost touch screen computers through multimedia audio-narrative and video messages. Studies have not tested the effectiveness of culturally tailored communications specified to stated "implementation intentions" for improving CRC screening in this group. A randomized design will test a comparison condition of generic information versus a multimedia tailored intervention that specifically addresses each participant's screening test modality preference, current CRC screening decisional stage (PAPM), and CRC screening "implementation intentions" (the "when", "where" and "how" details of screening). Behavioral intervention materials will be developed with the help of cultural experts, a pilot test, and from data gathered in a prior focus group study we used to assess key influences on CRC screening for AIs. The study will be conducted with 460 AI patients eligible for CRC screening and recruited while presenting for care in tribal or regional safety-net clinics. All participants will receive a baseline touch screen administered assessment and, depending on stated preference, be offered either an immunochemical fecal occult blood test (iFOBT-InSure TM) or colonoscopy. Participants will be randomized to either C (comparison group-computer delivered generic CRC information) or AI2 (active intervention-computer delivered culturally tailored messaging based on individual PAPM stage, behavior constructs, and "Implementation Intentions"). A brief office exit survey will assess patient-provider discussions of CRC screening and satisfaction with computerized message materials.

描述（由申请人提供）：结直肠癌 (CRC) 死亡率对少数族裔的影响尤为严重。很少有研究涉及对美洲印第安人 (AI) 等特定少数群体进行筛查。本研究将评估新型定制触摸屏计算机干预的有效性，该干预基于预防采用过程模型 (PAPM) 和“实施意图”概念的创新整合，“实施意图”是计划行为理论的最新阐述。大部分干预措施将在部落诊所和初级保健机构中通过多媒体音频叙述和视频信息在低成本触摸屏计算机上进行。研究尚未测试针对改善该群体的 CRC 筛查而指定的“实施意图”的文化定制沟通的有效性。随机设计将测试通用信息与多媒体定制干预的比较条件，该干预专门解决每个参与者的筛查测试方式偏好、当前 CRC 筛查决策阶段 (PAPM) 和 CRC 筛查“实施意图”（“何时”、“何处”） ”和“如何”筛选的详细信息）。行为干预材料将在文化专家、试点测试的帮助下开发，并根据之前焦点小组研究收集的数据来开发，我们用于评估人工智能对结直肠癌筛查的关键影响。该研究将对 460 名符合 CRC 筛查资格的 AI 患者进行，并在部落或地区安全网诊所接受护理时招募。所有参与者都将接受基线触摸屏评估，并根据所述偏好，接受免疫化学粪便潜血测试 (iFOBT-InSure TM) 或结肠镜检查。参与者将被随机分配到 C（对照组计算机提供通用 CRC 信息）或 AI2（主动干预计算机根据个人 PAPM 阶段、行为结构和“实施意图”提供文化定制的消息传递）。一项简短的办公室退出调查将评估患者与提供者对 CRC 筛查的讨论以及对计算机信息材料的满意度。